LIPIDIL

Lipidil Adverse Events Reported to the FDA Over Time

How are Lipidil adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lipidil, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lipidil is flagged as the suspect drug causing the adverse event.

Most Common Lipidil Adverse Events Reported to the FDA

What are the most common Lipidil adverse events reported to the FDA?

Liver Disorder	40 (3.01%)
Malaise	30 (2.26%)
Pyrexia	28 (2.11%)
Hepatic Function Abnormal	23 (1.73%)
Gamma-glutamyltransferase Increased	22 (1.65%)
Renal Failure Acute	22 (1.65%)
Drug Interaction	21 (1.58%)
Aspartate Aminotransferase Increase...	20 (1.5%)
Blood Creatinine Increased	20 (1.5%)
Myalgia	20 (1.5%)
Pneumonia	20 (1.5%)
	Show More
High Density Lipoprotein Decreased	19 (1.43%)
Liver Function Test Abnormal	18 (1.35%)
Blood Creatine Phosphokinase Increa...	17 (1.28%)
Fatigue	17 (1.28%)
Jaundice	16 (1.2%)
Pruritus	16 (1.2%)
Abdominal Pain	15 (1.13%)
Headache	15 (1.13%)
Interstitial Lung Disease	15 (1.13%)
Nausea	15 (1.13%)
Renal Impairment	15 (1.13%)
Alanine Aminotransferase Increased	14 (1.05%)
Dizziness	13 (.98%)
Rhabdomyolysis	13 (.98%)
Asthenia	12 (.9%)
Haematuria	12 (.9%)
Renal Failure	12 (.9%)
Blood Urea Increased	11 (.83%)
Chromaturia	11 (.83%)
Hepatic Failure	11 (.83%)
Anaemia	10 (.75%)
Arthralgia	10 (.75%)
Body Temperature	10 (.75%)
Rash	10 (.75%)
Confusional State	9 (.68%)
Gait Disturbance	9 (.68%)
Pancreatitis Acute	9 (.68%)
Abdominal Pain Upper	8 (.6%)
Blood Lactate Dehydrogenase Increas...	8 (.6%)
Blood Potassium Increased	8 (.6%)
Diabetes Mellitus	8 (.6%)
Dyspnoea	8 (.6%)
Hepatitis	8 (.6%)
Hypertriglyceridaemia	8 (.6%)
Pain In Extremity	8 (.6%)
Abdominal Compartment Syndrome	7 (.53%)
Abdominal Distension	7 (.53%)
Insomnia	7 (.53%)
Intestinal Perforation	7 (.53%)
Multi-organ Failure	7 (.53%)
Muscular Weakness	7 (.53%)
Myocardial Infarction	7 (.53%)
Oedema Peripheral	7 (.53%)
Pain	7 (.53%)
Sepsis	7 (.53%)
Tachypnoea	7 (.53%)
Toxic Epidermal Necrolysis	7 (.53%)
Unresponsive To Stimuli	7 (.53%)
Urticaria	7 (.53%)
White Blood Cell Count Increased	7 (.53%)
Abdominal Discomfort	6 (.45%)
Anorexia	6 (.45%)
Face Oedema	6 (.45%)
Insulin Resistance	6 (.45%)
Muscle Spasms	6 (.45%)
Thrombocytopenia	6 (.45%)
Abdominal Rigidity	5 (.38%)
Amnesia	5 (.38%)
Apnoea	5 (.38%)
Blister	5 (.38%)
Blood Bilirubin Increased	5 (.38%)
Choking	5 (.38%)
Diarrhoea	5 (.38%)
Eczema	5 (.38%)
Erythema	5 (.38%)
Eye Pain	5 (.38%)
Gastrooesophageal Reflux Disease	5 (.38%)
Intentional Overdose	5 (.38%)
Toxic Skin Eruption	5 (.38%)
Visual Field Defect	5 (.38%)
Angina Pectoris	4 (.3%)
Blood Triglycerides Increased	4 (.3%)
Cardiac Failure Congestive	4 (.3%)
Decreased Appetite	4 (.3%)
Discomfort	4 (.3%)
Dyspepsia	4 (.3%)
Generalised Erythema	4 (.3%)
Gout	4 (.3%)
Hypertension	4 (.3%)
Hypocholesterolaemia	4 (.3%)
Impaired Driving Ability	4 (.3%)
Lip Swelling	4 (.3%)
Lipase Increased	4 (.3%)
Memory Impairment	4 (.3%)
Muscle Disorder	4 (.3%)
Musculoskeletal Pain	4 (.3%)
Ocular Icterus	4 (.3%)
Overdose	4 (.3%)
Paresis	4 (.3%)
Shock	4 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lipidil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lipidil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lipidil

What are the most common Lipidil adverse events reported to the FDA?

Hepatic And Hepatobiliary	114 (8.57%)
Hepatobiliary	82 (6.17%)
Epidermal And Dermal Conditions	73 (5.49%)
Gastrointestinal Signs	70 (5.26%)
Muscle	53 (3.98%)
Renal Disorders	51 (3.83%)
Infections - Pathogen Unspecified	39 (2.93%)
Neurological	37 (2.78%)
Renal And Urinary Tract Investigati...	36 (2.71%)
Respiratory	35 (2.63%)
Lipid Analyses	30 (2.26%)
	Show More
Body Temperature Conditions	28 (2.11%)
Enzyme	28 (2.11%)
Urinary Tract Signs	26 (1.95%)
Therapeutic And Nontherapeutic Effe...	21 (1.58%)
Musculoskeletal And Connective Tiss...	20 (1.5%)
Glucose Metabolism Disorders	19 (1.43%)
Lower Respiratory Tract Disorders	19 (1.43%)
Movement Disorders	17 (1.28%)
Anemias Nonhemolytic And Marrow Dep...	16 (1.2%)
Hematology Investigations	16 (1.2%)
Headaches	15 (1.13%)
Joint	15 (1.13%)
Coronary Artery	14 (1.05%)
Exocrine Pancreas Conditions	14 (1.05%)
Lipid Metabolism	13 (.98%)
Physical Examination Topics	13 (.98%)
Medication Errors	11 (.83%)
Angiedema And Urticaria	10 (.75%)
Appetite And General Nutritional	10 (.75%)
Gastrointestinal Motility And Defec...	10 (.75%)
Sleep Disorders	10 (.75%)
Decreased And Nonspecific Blood Pre...	9 (.68%)
Deliria	9 (.68%)
Eye	9 (.68%)
Mental Impairment	9 (.68%)
Water, Electrolyte And Mineral	9 (.68%)
Gastrointestinal Ulceration And Per...	8 (.6%)
Central Nervous System Vascular	7 (.53%)
Gastrointestinal Conditions	7 (.53%)
Metabolic, Nutritional And Blood Ga...	7 (.53%)
Heart Failures	6 (.45%)
Oral Soft Tissue Conditions	6 (.45%)
Platelet	6 (.45%)
Cardiac And Vascular Investigations	5 (.38%)
Chemical Injury And Poisoning	5 (.38%)
Gastrointestinal	5 (.38%)
Lifestyle Issues	5 (.38%)
Neurological Disorders Of The Eye	5 (.38%)
Ocular Infections, Irritations And ...	5 (.38%)
Vascular Hypertensive	5 (.38%)
Bile Duct	4 (.3%)
Bronchial Disorders	4 (.3%)
Inner Ear And Viiith Cranial Nerve	4 (.3%)
Personality Disorders	4 (.3%)
Purine And Pyrimidine Metabolism	4 (.3%)
Reproductive Neoplasms Female Benig...	4 (.3%)
Vision	4 (.3%)
Diabetic Complications	3 (.23%)
Gastrointestinal Hemorrhages	3 (.23%)
Gastrointestinal Inflammatory Condi...	3 (.23%)
Gastrointestinal Neoplasms Malignan...	3 (.23%)
Miscellaneous And Site Unspecified ...	3 (.23%)
Obstetric And Gynecological Therape...	3 (.23%)
Pulmonary Vascular	3 (.23%)
Viral Infectious	3 (.23%)
White Blood Cell	3 (.23%)
Anterior Eye Structural Change, Dep...	2 (.15%)
Arteriosclerosis, Stenosis, Vascula...	2 (.15%)
Cardiac Arrhythmias	2 (.15%)
Depressed Mood Disorders	2 (.15%)
Disturbances In Thinking	2 (.15%)
Electrolyte And Fluid Balance Condi...	2 (.15%)
Embolism And Thrombosis	2 (.15%)
Gallbladder	2 (.15%)
Metabolic And Nutritional Disorders...	2 (.15%)
Ocular Structural Change, Deposit A...	2 (.15%)
Penile And Scrotal Disorders	2 (.15%)
Pleural	2 (.15%)
Protein And Chemistry Analyses	2 (.15%)
Seizures	2 (.15%)
Skin And Subcutaneous Tissue	2 (.15%)
Skin Appendage Conditions	2 (.15%)
Suicidal And Self-injurious Behavio...	2 (.15%)
Thyroid Gland	2 (.15%)
Tongue Conditions	2 (.15%)
Toxicology And Therapeutic Drug Mon...	2 (.15%)
Upper Respiratory Tract Disorders	2 (.15%)
Aural	1 (.08%)
Bacterial Infectious	1 (.08%)
Benign Neoplasms Gastrointestinal	1 (.08%)
Connective Tissue Disorders	1 (.08%)
Dental And Gingival Conditions	1 (.08%)
Fatal Outcomes	1 (.08%)
Glaucoma And Ocular Hypertension	1 (.08%)
Hematological And Lymphoid Tissue T...	1 (.08%)
Injuries	1 (.08%)
Mood Disorders	1 (.08%)
Musculoskeletal And Soft Tissue Inv...	1 (.08%)
Nephropathies	1 (.08%)
Ocular Hemorrhages And Vascular	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lipidil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lipidil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.